Anna Eshoo: “When a company delays the start of the exclusivity period of a product, it not only delays other generics from coming to…”

In 1997 this subcommittee held a joint hearing with the Senate Labor Committee to review our Nation's system for organ transplant.

I continue to ask Congress to authorize the FAA to lead community roundtables to address noise issues.

I see, as I expressed to you when we spoke, a disconnect between CMS, the FDA, and the VA on new treatments for mild Alzheimer's.

The Medicaid Value-Based Payments for Patients Act will codify a CMS rule to help ensure Medicaid enrollees have access to breakthrough gene therapies.